Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

NCT01216839 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Refractory or Relapsed RMS and Soft Tissue Sarcomas

Interventions

DRUG: Everolimus

Sponsor

Sidnei Epelman